Abstract | OBJECTIVE: DATA SOURCES: STUDY SELECTIONS: This review focused on the key trials that led to the inclusion of LAMAs in asthma guidelines. In addition, we highlighted a number of studies with other study designs and populations. RESULTS: We identified 6 major studies that led to inclusion in asthma guidelines and 3 studies with other study designs and populations. CONCLUSION:
|
Authors | Susan Muiser, Reinoud Gosens, Maarten van den Berge, Huib A M Kerstjens |
Journal | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
(Ann Allergy Asthma Immunol)
Vol. 128
Issue 4
Pg. 352-360
(04 2022)
ISSN: 1534-4436 [Electronic] United States |
PMID | 35074516
(Publication Type: Journal Article, Review)
|
Copyright | Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Adrenal Cortex Hormones
- Adrenergic beta-2 Receptor Agonists
- Muscarinic Antagonists
- Tiotropium Bromide
|
Topics |
- Administration, Inhalation
- Adrenal Cortex Hormones
(therapeutic use)
- Adrenergic beta-2 Receptor Agonists
(therapeutic use)
- Asthma
(drug therapy)
- Drug Therapy, Combination
- Humans
- Muscarinic Antagonists
(therapeutic use)
- Pulmonary Disease, Chronic Obstructive
(drug therapy)
- Tiotropium Bromide
(therapeutic use)
|